DeNova Inc.

7 records totalling $4,963,181.00 CAD, from official Government of Canada open data.

Embed this chart

By department

National Research Council Canada $4,963,181 7 records

Records

DeNova Inc. $2,926,997.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
FY 2025-2026
Canada

DeNova is advancing the scale-up of its methanol-fed microbial fermentation process to enable efficient, reliable, and low-impact production at demonstration scale. This project focuses on technical d...

DeNova Inc. $786,156.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

DeNova is optimizing and scaling up the fermentation and up- and down-stream processes of its single cell protein production in preparation for commercialization.

DeNova Inc. $483,348.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
FY 2024-2025
Canada

Advancing Innovative Microbial Fermentation Technologies for Sustainable Aquafeed Production

DeNova Inc. $322,776.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2019-2020
Canada

DeNova is conducting experimentation to validate the efficacy of its single cell protein product and to scale up production processes in preparation for commercialization.

DeNova Inc. $269,706.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2016-2017
Canada

DeNova is selecting an organism to be used in a process to produce single cell protein.

DENOVA INC. $143,706.00
National Research Council Canada | Conseil national de recherches Canada
FY 2016-2017
Canada
DeNova Inc. $30,492.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.